4.7 Article

Remodeling of microbiota gut-brain axis using psychobiotics in depression

期刊

EUROPEAN JOURNAL OF PHARMACOLOGY
卷 931, 期 -, 页码 -

出版社

ELSEVIER
DOI: 10.1016/j.ejphar.2022.175171

关键词

Neurotransmitters; Short chain fatty acids; Gut peptides; Inflammation; Treatment-resistant depression; Gut microbiota

资金

  1. Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India
  2. National Institute of Pharmaceutical Education and Research (NIPER) , Hyderabad

向作者/读者索取更多资源

Depression is a complex disorder involving various systems, including neuroendocrine, neurochemical, immune, and metabolic systems. Recent studies have shown the significant connection between gut microbiota and central nervous system disorders. Understanding the new mechanisms underlying the interaction between gut microbiota and the brain is important for depression management. Restoring gut microbiota with methods like using prebiotics, probiotics, postbiotics, synbiotics, and fermented foods has gained attention as a promising approach for depression treatment. Furthermore, evidence suggests the role of gut microbiota in the treatment of resistant depression. Therefore, remodeling the microbiota-gut-brain axis using psychobiotics is a potential therapeutic strategy for reversing psychiatric disorders, and investigating the underlying mechanisms for gut-brain crosstalk is imperative.
Depression is a multifaceted psychiatric disorder mainly orchestrated by dysfunction of neuroendocrine, neurochemical, immune, and metabolic systems. The interconnection of gut microbiota perturbation with the central nervous system disorders has been well documented in recent times. Indeed, alteration of commensal intestinal microflora is noted in several psychiatric disorders such as anxiety and depression, which are presumed to be routed through the enteric nervous system, autonomic nervous system, endocrine, and immune system. This review summarises the new mechanisms underlying the crosstalk between gut microbiota and brain involved in the management of depression. Depression-induced changes in the commensal intestinal microbiota are majorly linked with the disruption of gut integrity, hyperinflammation, and modulation of short-chain fatty acids, neurotransmitters, kynurenine metabolites, endocannabinoids, brain-derived neurotropic factors, hypothalamic-pituitary-adrenal axis, and gut peptides. The restoration of gut microbiota with prebiotics, pro-biotics, postbiotics, synbiotics, and fermented foods (psychobiotics) has gained a considerable attention for the management of depression. Recent evidence also propose the role of gut microbiota in the process of treatment -resistant depression. Thus, remodeling of the microbiota-gut-brain axis using psychobiotics appears to be a promising therapeutic approach for the reversal of psychiatric disorders, and it is imperative to decipher the underlying mechanisms for gut-brain crosstalk.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据